American International Group, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $119,438 - $125,486	824 Added 2.83%	29,981 $4.53 Million
Q2 2022 Aug 12, 2022	BUY	$83.14 - $145.99 $125,042 - $219,568	1,504 Added 5.44%	29,157 $4.25 Million
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $214,325 - $278,265	-1,947 Reduced 6.58%	27,653 $3.28 Million
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $88,261 - $131,404	-885 Reduced 2.9%	29,600 $4.08 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $20,857 - $29,310	211 Added 0.7%	30,485 $4.24 Million
Q2 2021 Aug 13, 2021	SELL	$65.78 - $105.02 $31,508 - $50,304	-479 Reduced 1.56%	30,274 $2.94 Million
Q1 2021 May 07, 2021	SELL	$64.07 - $91.75 $18,324 - $26,240	-286 Reduced 0.92%	30,753 $2.1 Million
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $147,578 - $222,808	2,268 Added 7.88%	31,039 $2.66 Million
Q3 2020 Nov 04, 2020	SELL	$59.04 - $77.95 $5,018 - $6,625	-85 Reduced 0.29%	28,771 $1.87 Million
Q2 2020 Aug 12, 2020	BUY	$29.01 - $74.23 $102,376 - $261,957	3,529 Added 13.93%	28,856 $2.11 Million
Q1 2020 May 04, 2020	BUY	$27.51 - $57.29 $22,998 - $47,894	836 Added 3.41%	25,327 $862,000
Q4 2019 Feb 05, 2020	SELL	$40.86 - $57.65 $8,458 - $11,933	-207 Reduced 0.84%	24,491 $1.33 Million
Q3 2019 Nov 08, 2019	BUY	$37.38 - $49.47 $131,876 - $174,530	3,528 Added 16.67%	24,698 $1.03 Million
Q2 2019 Aug 23, 2019	BUY	$39.79 - $67.01 $842,354 - $1.42 Million	21,170 New	21,170 $927,000
Q2 2019 Aug 13, 2019	SELL	$39.79 - $67.01 $792,696 - $1.33 Million	-19,922 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$34.52 - $53.29 $41,976 - $64,800	1,216 Added 6.5%	19,922 $1.03 Million
Q4 2018 Feb 13, 2019	SELL	$29.75 - $42.9 $4,254 - $6,134	-143 Reduced 0.76%	18,706 $692,000
Q3 2018 Nov 09, 2018	BUY	$32.79 - $43.0 $34,134 - $44,763	1,041 Added 5.85%	18,849 $708,000
Q2 2018 Aug 08, 2018	SELL	$23.62 - $42.29 $58,931 - $105,513	-2,495 Reduced 12.29%	17,808 $704,000
Q1 2018 May 07, 2018	BUY	$22.49 - $34.56 $297,565 - $457,263	13,231 Added 187.09%	20,303 $523,000
Q4 2017 Feb 09, 2018	BUY	$20.44 - $35.56 $7,481 - $13,014	366 Added 5.46%	7,072 $191,000
Q3 2017 Nov 09, 2017	BUY	$23.54 - $38.21 $157,859 - $256,236	6,706	6,706 $251,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account